Statera Biopharma, Inc. (STAB)
STAB Stock Price Chart
Explore Statera Biopharma, Inc. interactive price chart. Choose custom timeframes to analyze STAB price movements and trends.
STAB Company Profile
Discover essential business fundamentals and corporate details for Statera Biopharma, Inc. (STAB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Jul 2021
Employees
46.00
Website
https://www.staterabiopharma.comCEO
Blake Hawley
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.
STAB Financial Timeline
Browse a chronological timeline of Statera Biopharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Jun 2024
Earnings released on 17 May 2024
Earnings released on 12 Feb 2024
Earnings released on 8 Sept 2023
Earnings released on 29 Aug 2023
Earnings released on 29 May 2023
Earnings released on 13 Feb 2023
Earnings released on 14 Nov 2022
EPS came in at -$0.07 , while revenue for the quarter reached $670.47K .
Earnings released on 28 Oct 2022
EPS came in at -$0.08 , while revenue for the quarter reached $768.83K .
Earnings released on 21 Oct 2022
EPS came in at -$0.23 , while revenue for the quarter reached $997.84K .
Earnings released on 5 Oct 2022
EPS came in at -$2.20 , while revenue for the quarter reached $1.25M .
Earnings released on 15 Nov 2021
EPS came in at -$0.47 , while revenue for the quarter reached $236.52K .
Earnings released on 16 Aug 2021
EPS came in at -$0.26 .
Earnings released on 14 May 2021
EPS came in at -$0.21 .
Earnings released on 22 Mar 2021
EPS came in at -$0.16 , while revenue for the quarter reached -$63.26K .
Earnings released on 16 Nov 2020
EPS came in at -$0.22 .
STAB Stock Performance
Access detailed STAB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.